Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007872
Filing Date
2025-05-15
Accepted
2025-05-15 16:01:33
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250331x10q.htm   iXBRL 10-Q 1232877
2 EX-31.1 tmb-20250331xex31d1.htm EX-31.1 10463
3 EX-31.2 tmb-20250331xex31d2.htm EX-31.2 10349
4 EX-32.1 tmb-20250331xex32d1.htm EX-32.1 6533
5 EX-32.2 tmb-20250331xex32d2.htm EX-32.2 6264
  Complete submission text file 0001558370-25-007872.txt   6744675

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20250331.xsd EX-101.SCH 49659
7 EX-101.CAL tmb-20250331_cal.xml EX-101.CAL 44877
8 EX-101.DEF tmb-20250331_def.xml EX-101.DEF 221193
9 EX-101.LAB tmb-20250331_lab.xml EX-101.LAB 462835
10 EX-101.PRE tmb-20250331_pre.xml EX-101.PRE 363433
76 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250331x10q_htm.xml XML 1170062
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 25952396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)